(Q78815186)
Statements
Treatment of active Crohn's disease with onercept (recombinant human soluble p55 tumour necrosis factor receptor): results of a randomized, open-label, pilot study (English)
L Lemmens
G Van Assche
M Noman
I Borghini-Fuhrer
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference